Healthcare provider profile · identity verified

Jeremy Day, MD

Family Practice · HASTINGS, MN · NPI 1346660883

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	372	105
Lisinopril	Lisinopril	318	87
Amlodipine Besylate	Amlodipine Besylate	302	88
Gabapentin	Gabapentin	264	52
Omeprazole	Omeprazole	212	64
Levothyroxine Sodium	Levothyroxine Sodium	199	55
Losartan Potassium	Losartan Potassium	194	59
Metformin Hcl	Metformin Hcl	189	56
Metoprolol Succinate	Metoprolol Succinate	178	47
Albuterol Sulfate Hfa	Albuterol Sulfate	172	41
Rosuvastatin Calcium	Rosuvastatin Calcium	145	46
Potassium Chloride	Potassium Chloride	127	29
Simvastatin	Simvastatin	122	36
Sertraline Hcl	Sertraline Hcl	118	32
Trazodone Hcl	Trazodone Hcl	116	29
Furosemide	Furosemide	110	32
Hydrochlorothiazide	Hydrochlorothiazide	110	36
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	106	27
Carvedilol	Carvedilol	97	28
Meloxicam	Meloxicam	97	29
Pantoprazole Sodium	Pantoprazole Sodium	91	28
Metoprolol Tartrate	Metoprolol Tartrate	84	27
Tamsulosin Hcl	Tamsulosin Hcl	80	26
Fluticasone Propionate	Fluticasone Propionate	78	37
Escitalopram Oxalate	Escitalopram Oxalate	66	18
Tramadol Hcl	Tramadol Hcl	65	23
Duloxetine Hcl	Duloxetine Hcl	64	20
Famotidine	Famotidine	64	16
Baclofen	Baclofen	61	18
Clopidogrel	Clopidogrel Bisulfate	61	19
Warfarin Sodium	Warfarin Sodium	61	suppressed
Allopurinol	Allopurinol	57	19
Xarelto	Rivaroxaban	56	15
Montelukast Sodium	Montelukast Sodium	55	17
Pregabalin	Pregabalin	54	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	suppressed
Eliquis	Apixaban	53	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	19
Spironolactone	Spironolactone	48	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	14
Ezetimibe	Ezetimibe	46	15
Prednisone	Prednisone	44	19
Ozempic	Semaglutide	43	suppressed
Celecoxib	Celecoxib	42	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	12
Alendronate Sodium	Alendronate Sodium	39	15
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Januvia	Sitagliptin Phosphate	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	13
Diclofenac Sodium	Diclofenac Sodium	37	suppressed
Bupropion Xl	Bupropion Hcl	34	11
Lorazepam	Lorazepam	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	11
Metformin Hcl Er	Metformin Hcl	33	12
Mirtazapine	Mirtazapine	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Levetiracetam	Levetiracetam	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Atenolol	Atenolol	30	suppressed
Buspirone Hcl	Buspirone Hcl	28	14
Alprazolam	Alprazolam	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Finasteride	Finasteride	26	suppressed
Fluconazole	Fluconazole	26	13
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	11
Azithromycin	Azithromycin	24	20
Cephalexin	Cephalexin	24	15
Naproxen	Naproxen	24	suppressed
Topiramate	Topiramate	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Glipizide	Glipizide	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Nystatin	Nystatin	22	16
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Dexlansoprazole Dr	Dexlansoprazole	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Amoxicillin	Amoxicillin	20	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Ketoconazole	Ketoconazole	19	16
Linzess	Linaclotide	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Torsemide	Torsemide	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Glyburide	Glyburide	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Glipizide Er	Glipizide	12	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Valsartan	Valsartan	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error